MANCHESTER, England, October 4, 2016
MANCHESTER, England, October 4, 2016 /PRNewswire/ --
Premier League club Manchester City have signed healthcare and pharmaceutical business Mundipharma as one of their most recent regional partners.
The multi-year deal sees Mundipharma Pte Ltd named the 'Official Healthcare Product Partner of Manchester City Football Club' in Mundipharma's markets in Asia Pacific, Latin America, the Middle East and Africa. It reflects both partners' commitment to deepening the connection they have with their fans and people in those emerging markets.
Under the partnership, Mundipharma will be incorporating Manchester City branding in a selection of their marketing and advertising campaigns and the logo of its popular range of BETADINE medicines will feature on the sleeve of the Club's medical staff at friendly matches in Asia Pacific, Latin America, the Middle East and Africa.
As the partnership progresses, Mundipharma will also collaborate with the Club to offer young fans the opportunity to travel to Manchester for an unforgettable football experience at the Club's elite youth development and training facility, the City Football Academy. On the trip, young fans will enjoy training sessions delivered by qualified City Football Schools' coaches dedicated to providing participants with an authentic Manchester City experience.
Speaking as the partnership was announced at the City Football Academy, Manchester City's elite youth development and training facility, Raman Singh, President, Mundipharma, Asia Pacific, Latin America, the Middle East and Africa, said:
" We are proud to become an Official Healthcare Product Partner of Manchester City Football Club. Manchester City are one of the world ' s best football teams and are known all over the world. Sports reaches and inspires people around the world. We intend to harness this power to raise awareness on key health issues such as prevent ing the spread of infectious diseases , which is a major focus for us in emerging markets where there have been a number of recent outbreaks.
Echoing Mr Singh's sentiments, Manchester City's Chief Operating Officer, Omar Berrada, said:
"We are delighted to announce our partnership with Mundipharma,who likeManchester City continually strive for excellence.Their commitment to connecting with their in-market consumers in innovative and meaningful ways reflects that of Manchester Citymaking them a fitting partner for the Club. We look forward to working together across emerging markets, where our fanbase also continues to grow."
Manchester City, who have 400 million followers around the world, are currently enjoying a successful start to the season, under the guidance of manager Pep Guardiola.
Mundipharma's emerging markets business has grown significantly in recent years and its medicines are distributed in more than 120 countries worldwide.
Mundipharma's independent associated companies are privately owned entities covering the world's pharmaceutical markets. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients with cancer and non-cancer pain and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients with severe and debilitating diseases the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.
For more information, please visit: http://www.mundipharma.com.sg
About Manchester City Football Club
Manchester City FC is an English Premier League club whose roots began in East Manchester in 1880 as St Mark's West Gorton. It officially became Manchester City FC in 1894 and has since then gone onto win the European Cup Winners' Cup, four League Championship titles, including two Premier League titles, and five FA Cups. Manchester City FC is one of four teams comprising the City Football Group and counts New York City FC, Melbourne City FC and Yokohama F-Marinos among its sister clubs.
Under manager Pep Guardiola, one of the most highly decorated managers in world football, the Club plays its domestic and Champions' League home fixtures at the Etihad Stadium, a spectacular 55,000 seat arena that City have called home since 2003. Today, the Stadium sits on the wider Etihad Campus, which also encompasses the City Football Academy, a world-leading first team training and youth development facility located in the heart of East Manchester. Featuring a 7,000 capacity Academy Stadium, the City Football Academy is also where Manchester City Women's Football Club and the Elite Development Squad train on a daily basis and play their competitive home games.
For more information, please visit http://www.mancity.com
®: Betadine is a Registered Trademark.
SOURCE MundipharmaPR Newswire
Last updated on: 04/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.